Latest Targeted Medical (TRGM) Headlines
Targeted Medical Pharma names Dr Thomas Wenkart to board
M2 - Tue Mar 11, 7:19AM CDT
US-based biotechnology company Targeted Medical Pharma (Other OTC:TRGM) revealed on Monday the addition of Dr Thomas Wenkart to its board of directors.
Healthcare Executive Dr. Thomas Wenkart Joins Targeted Medical Pharma's Board of Directors
Business Wire - Mon Mar 10, 10:59PM CDT
Targeted Medical Pharma, Inc. (OTCQB:TRGM) today announced that Dr. Thomas Wenkart, Chief Executive and Chairman at Macquarie Health Corporation, has joined the company's board of directors.
Targeted Medical Pharma signs promotion and distribution agreement for Clearwayz
M2 - Tue Feb 11, 7:06AM CST
US-based biotechnology company Targeted Medical Pharma Inc (Other OTC:TRGM) revealed on Monday the completion of a promotion and distribution agreement for Clearwayz using direct-response television commercials and internet promotion for select audiences in major markets.
Targeted Medical Pharma Inc unveils new dietary supplement for healthy sinus and immune function, Clearwayz
M2 - Thu Nov 14, 9:39AM CST
Biotechnology company Targeted Medical Pharma Inc (Other OTC:TRGM) reported on Wednesday the availability of the dietary supplement specially formulated to support healthy sinus and immune function, the Clearwayz.
Targeted Medical Pharma begins clinical trial of new medical food for Autism Spectrum Disorders, with impaired absorption and increased nutritional requirements
M2 - Mon Sep 02, 5:05AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) reported on Friday the start of a clinical trial of a new medical food indicated for the dietary management of Autism and Autism Spectrum Disorders.
OTC Daily Alert Stock Watch - Targeted Medical Pharma, Inc (OTCQB: TRGM)
WorldStockWire - Fri Aug 30, 7:45PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Targeted Medical Pharma Inc forms dietary supplement division, with first market launch in November 2013
M2 - Fri Aug 30, 8:09AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) revealed on Thursday the establishment of a new division that will specialise in the manufacturing and distribution of a proprietary line of dietary supplements.
Targeted Medical Pharma Establishes Dietary Supplement Division
Business Wire - Thu Aug 29, 7:00AM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced the launch of a new division that will specialize in the manufacturing and distribution of a proprietary line of dietary supplements.
Targeted Medical Pharma Inc appoints William B Horne as CFO
M2 - Thu Aug 22, 7:00AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) revealed on Wednesday the addition of William B Horne as its chief financial officer.
Targeted Medical Pharma Selects William B. Horne as Chief Financial Officer
Business Wire - Wed Aug 21, 4:56PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced the appointment of William B. Horne as the company's Chief Financial Officer. He will oversee all aspects of the company's fiscal operations and financial reporting.
Targeted Medical Pharma Reports 2013 Second Quarter Financial Results
Business Wire - Wed Aug 14, 6:33PM CDT
Targeted Medical Pharma, Inc. (OTCQB:TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced financial results for its second quarter ended June 30, 2013. The Company continued to post increasing revenue for the second quarter and first half of 2013 compared to the second quarter and first half of 2012.
Targeted Medical Pharma to Present at 2013 Southern California Investor Conference
Business Wire - Tue Aug 06, 4:32PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies for the treatment of chronic disease, today announced that the company's CEO and Chief Science Officer William Shell, M.D., will be presenting at the 2013 Southern California Investor Conference being held at the Island Hotel in Newport Beach, California on Thursday, August 8, 2013 at 8:30 a.m. PDT.
Targeted Medical Pharma Inc announces increase in use of prescription-only medical foods in Pacific Northwest and Hawaii
M2 - Thu Jul 18, 8:05AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) reported on Wednesday a rise in sales of its prescription-only medical foods in Pacific Northwest and Hawaii.
Use of Prescription-Only Medical Foods Increases in Pacific Northwest and Hawaii
Business Wire - Wed Jul 17, 7:00AM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced that 23 new medical clinics in Washington, Oregon and Hawaii are now purchasing and prescribing the company's prescription-only medical foods, bringing the total to 69 health facilities in those three states.
Targeted Medical Pharma Inc awarded USD3.28m in funding
M2 - Wed Jul 03, 4:27AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) reported on Tuesday the receipt of USD3.28m from the securitization of certain aged receivables through an agreement with Cambridge Medical Funding Group LLC (CMFG), a finance solutions company.
Targeted Medical Pharma Secures $3.28 Million in Funding
Business Wire - Tue Jul 02, 7:00AM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies for the treatment of chronic disease, today announced it secured $3.28 million from the securitization of certain aged receivables through an agreement with New Jersey-based Cambridge Medical Funding Group, LLC ("CMFG"). CMFG funded $750,000 on June 29, 2013 and has agreed to fund the balance before July 31, 2013.
Targeted Medical Pharma Engages Marcum LLP as New Auditors
Business Wire - Thu Jun 13, 7:00AM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced it has engaged Marcum LLP as the company's new independent auditor. The new accounting firm will be the signing auditor for the company's 2013 second quarter filing.
Survey Shows Most Americans Do Not Get a Good Night's Sleep
Business Wire - Mon Jun 03, 7:00AM CDT
Eighty three percent of Americans say they do not always get a good night's sleep on a regular basis, according to the 2013 Rx Sleep Survey conducted by Harris Interactive on behalf of Targeted Medical Pharma, Inc. (OTCQB: TRGM), a Los Angeles-based biotechnology company.
Targeted Medical Pharma to Present at Marcum MicroCap Conference
Business Wire - Wed May 22, 1:47PM CDT
Targeted Medical Pharma, Inc. (OTCBB: TRGM), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced that its Chief Executive and Chief Science Officer, Dr. William Shell, will be presenting at the Marcum MicroCap Conference.
Targeted Medical Pharma Reports 2013 First Quarter Results
Business Wire - Wed May 15, 5:30PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced financial results for its first quarter ended March 31, 2013. The Company posted record quarterly revenue of $2.811 million for the first quarter ended March 31, 2013, compared to revenue of $1.375 million for the first quarter ended March 31, 2012, an increase of 104.4 percent.
Targeted Medical Pharma names Dr Thomas Wenkart to board
M2 - Tue Mar 11, 7:19AM CDT
US-based biotechnology company Targeted Medical Pharma (Other OTC:TRGM) revealed on Monday the addition of Dr Thomas Wenkart to its board of directors.
Healthcare Executive Dr. Thomas Wenkart Joins Targeted Medical Pharma's Board of Directors
Business Wire - Mon Mar 10, 10:59PM CDT
Targeted Medical Pharma, Inc. (OTCQB:TRGM) today announced that Dr. Thomas Wenkart, Chief Executive and Chairman at Macquarie Health Corporation, has joined the company's board of directors.
Targeted Medical Pharma signs promotion and distribution agreement for Clearwayz
M2 - Tue Feb 11, 7:06AM CST
US-based biotechnology company Targeted Medical Pharma Inc (Other OTC:TRGM) revealed on Monday the completion of a promotion and distribution agreement for Clearwayz using direct-response television commercials and internet promotion for select audiences in major markets.
Targeted Medical Pharma Inc unveils new dietary supplement for healthy sinus and immune function, Clearwayz
M2 - Thu Nov 14, 9:39AM CST
Biotechnology company Targeted Medical Pharma Inc (Other OTC:TRGM) reported on Wednesday the availability of the dietary supplement specially formulated to support healthy sinus and immune function, the Clearwayz.
Targeted Medical Pharma begins clinical trial of new medical food for Autism Spectrum Disorders, with impaired absorption and increased nutritional requirements
M2 - Mon Sep 02, 5:05AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) reported on Friday the start of a clinical trial of a new medical food indicated for the dietary management of Autism and Autism Spectrum Disorders.
OTC Daily Alert Stock Watch - Targeted Medical Pharma, Inc (OTCQB: TRGM)
WorldStockWire - Fri Aug 30, 7:45PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Targeted Medical Pharma Inc forms dietary supplement division, with first market launch in November 2013
M2 - Fri Aug 30, 8:09AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) revealed on Thursday the establishment of a new division that will specialise in the manufacturing and distribution of a proprietary line of dietary supplements.
Targeted Medical Pharma Establishes Dietary Supplement Division
Business Wire - Thu Aug 29, 7:00AM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced the launch of a new division that will specialize in the manufacturing and distribution of a proprietary line of dietary supplements.
Targeted Medical Pharma Inc appoints William B Horne as CFO
M2 - Thu Aug 22, 7:00AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) revealed on Wednesday the addition of William B Horne as its chief financial officer.
Targeted Medical Pharma Selects William B. Horne as Chief Financial Officer
Business Wire - Wed Aug 21, 4:56PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced the appointment of William B. Horne as the company's Chief Financial Officer. He will oversee all aspects of the company's fiscal operations and financial reporting.
Targeted Medical Pharma Reports 2013 Second Quarter Financial Results
Business Wire - Wed Aug 14, 6:33PM CDT
Targeted Medical Pharma, Inc. (OTCQB:TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced financial results for its second quarter ended June 30, 2013. The Company continued to post increasing revenue for the second quarter and first half of 2013 compared to the second quarter and first half of 2012.
Targeted Medical Pharma to Present at 2013 Southern California Investor Conference
Business Wire - Tue Aug 06, 4:32PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies for the treatment of chronic disease, today announced that the company's CEO and Chief Science Officer William Shell, M.D., will be presenting at the 2013 Southern California Investor Conference being held at the Island Hotel in Newport Beach, California on Thursday, August 8, 2013 at 8:30 a.m. PDT.
Targeted Medical Pharma Inc announces increase in use of prescription-only medical foods in Pacific Northwest and Hawaii
M2 - Thu Jul 18, 8:05AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) reported on Wednesday a rise in sales of its prescription-only medical foods in Pacific Northwest and Hawaii.
Use of Prescription-Only Medical Foods Increases in Pacific Northwest and Hawaii
Business Wire - Wed Jul 17, 7:00AM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced that 23 new medical clinics in Washington, Oregon and Hawaii are now purchasing and prescribing the company's prescription-only medical foods, bringing the total to 69 health facilities in those three states.
Targeted Medical Pharma Inc awarded USD3.28m in funding
M2 - Wed Jul 03, 4:27AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) reported on Tuesday the receipt of USD3.28m from the securitization of certain aged receivables through an agreement with Cambridge Medical Funding Group LLC (CMFG), a finance solutions company.
Targeted Medical Pharma Secures $3.28 Million in Funding
Business Wire - Tue Jul 02, 7:00AM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies for the treatment of chronic disease, today announced it secured $3.28 million from the securitization of certain aged receivables through an agreement with New Jersey-based Cambridge Medical Funding Group, LLC ("CMFG"). CMFG funded $750,000 on June 29, 2013 and has agreed to fund the balance before July 31, 2013.
Targeted Medical Pharma Engages Marcum LLP as New Auditors
Business Wire - Thu Jun 13, 7:00AM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced it has engaged Marcum LLP as the company's new independent auditor. The new accounting firm will be the signing auditor for the company's 2013 second quarter filing.
Survey Shows Most Americans Do Not Get a Good Night's Sleep
Business Wire - Mon Jun 03, 7:00AM CDT
Eighty three percent of Americans say they do not always get a good night's sleep on a regular basis, according to the 2013 Rx Sleep Survey conducted by Harris Interactive on behalf of Targeted Medical Pharma, Inc. (OTCQB: TRGM), a Los Angeles-based biotechnology company.
Targeted Medical Pharma to Present at Marcum MicroCap Conference
Business Wire - Wed May 22, 1:47PM CDT
Targeted Medical Pharma, Inc. (OTCBB: TRGM), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced that its Chief Executive and Chief Science Officer, Dr. William Shell, will be presenting at the Marcum MicroCap Conference.
Targeted Medical Pharma Reports 2013 First Quarter Results
Business Wire - Wed May 15, 5:30PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced financial results for its first quarter ended March 31, 2013. The Company posted record quarterly revenue of $2.811 million for the first quarter ended March 31, 2013, compared to revenue of $1.375 million for the first quarter ended March 31, 2012, an increase of 104.4 percent.
